Gland Pharma Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is LEVOTHYROXINE SODIUM USP, with a corresponding US DMF Number 29550.
Remarkably, this DMF maintains an Active status since its submission on July 27, 2015, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of September 25, 2015, and payment made on August 17, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II